Telaprevir for Chronic HCV Infection REPLY

被引：0
|
作者：
McHutchison, John [1 ]
Pawlotsky, Jean-Michel [2 ]
Zeuzem, Stefan [3 ]
机构：
[1] Duke Univ, Durham, NC 27715 USA
[2] Henri Mondor Univ Hosp, F-94010 Creteil, France
[3] JW Goethe Univ Hosp, D-60590 Frankfurt, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 05期
关键词：
HEPATITIS-C;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：534 / 535
页数：2
相关论文
共 50 条
  • [31] Ombitasvir/paritaprevir/ritonavir plus dasabuvir combination in the treatment of chronic HCV infection
    Lucejko, Mariusz
    Parfieniuk-Kowerda, Anna
    Flisiak, Robert
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (08) : 1153 - 1164
  • [32] Modeling and Simulation Support Eltrombopag Dosing in Thrombocytopenic Patients with Chronic HCV Infection
    Zhang, Jianping
    Thapar, Mita
    Farrell, Colm
    Wire, Mary B.
    PHARMACEUTICAL RESEARCH, 2015, 32 (06) : 2015 - 2028
  • [33] Therapeutic response in children with post malignancy chronic HCV genotype 1 infection
    Urganci, Nafiye
    Gulec, Seda Geylani
    Polat, Tugcin Bora
    Vural, Sema
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2009, 44 (02): : 68 - 72
  • [34] Reversal of Immunity After Clearance of Chronic HCV Infection-All Reset?
    Wedemeyer, Heiner
    Khera, Tanvi
    Strunz, Benedikt
    Bjorkstrom, Niklas K.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [35] Review of boceprevir and telaprevir for the treatment of chronic hepatitis C
    Wilby, Kyle J.
    Partovi, Nilufar
    Ford, Jo-Ann E.
    Greanya, Erica D.
    Yoshida, Eric M.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (04) : 205 - 210
  • [36] Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection
    Gunduz, Feyza
    Mallikarjun, Chaithanya
    Balart, Luis A.
    Dash, Srikanta
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 96 (01) : 36 - 41
  • [37] Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2
    Seki, Nobuyoshi
    Sugita, Tomonori
    Aida, Yuta
    Itagaki, Munenori
    Ishiguro, Haruya
    Sutoh, Satoshi
    Abe, Hiroshi
    Tsubota, Akihito
    Matsushima, Masato
    Aizawa, Yoshio
    HEPATOLOGY INTERNATIONAL, 2014, 8 (04) : 550 - 559
  • [38] Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2
    Nobuyoshi Seki
    Tomonori Sugita
    Yuta Aida
    Munenori Itagaki
    Haruya Ishiguro
    Satoshi Sutoh
    Hiroshi Abe
    Akihito Tsubota
    Masato Matsushima
    Yoshio Aizawa
    Hepatology International, 2014, 8 : 550 - 559
  • [39] Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes
    Wilder, Julius M.
    Muir, Andrew J.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (06) : 314 - 327
  • [40] The impact and effect of liver insufficiency of HCV infection on patients with chronic obstructive pulmonary diseases
    El-Habashy, Mahmoud M.
    Eldahdouh, Samy S.
    Mohamed, Anwar A.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2014, 63 (01): : 81 - 85
12345